International Journal of Experimental Dental Science

Register      Login

VOLUME 4 , ISSUE 1 ( January-June, 2015 ) > List of Articles

RESEARCH ARTICLE

Localized Gingival Enlargement induced by Systemic Administration of Phenytoin for the Management of Epidermolysis Bullosa

K Smitha Gowda, Shilpa Vinod

Citation Information : Gowda KS, Vinod S. Localized Gingival Enlargement induced by Systemic Administration of Phenytoin for the Management of Epidermolysis Bullosa. Int J Experiment Dent Sci 2015; 4 (1):58-61.

DOI: 10.5005/jp-journals-10029-1096

License: CC BY-SA 3.0

Published Online: 01-06-2015

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract

How to cite this article

Gowda KS, Vinod S. Localized Gingival Enlargement induced by Systemic Administration of Phenytoin for the Management of Epidermolysis Bullosa. Int J Experiment Dent Sci 2015;4(1):58-61.


PDF Share
  1. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-950.
  2. Management of the oral surgery patient diagnosed with epidermolysis bullosa: report of 3 cases and review of the literature. J Oral Maxillofac Surg 2008 Mar;66(3):554-559.
  3. Orthodontic treatment of a patient with recessive dystrophic epidermolysis bullosa: a case report. Spec Care Dentist 2008;28(4):136-139.
  4. Dental and anesthetic management of a child with epidermolysis bullosa. J Ind Soc Pedod Prev Dent 2011;29(2):155-160.
  5. Epidermolysis bullosa. HU Rev 2000;26:221-227.
  6. Phenytoin therapy of recessive dystrophic epidermolysis bullosa—clinical trial and proposed mechanism of action on collagenase. N Engl J Med 1980 Oct;303:776-781.
  7. A hereditary epidermolysis bullosa: oral manifestations and dental therapy. Oral Surg Oral Med Oral Pathol 1976 Oct;42(4):490-500.
  8. Oral manifestations of epidermolysis bullosa. In: Fine JD, Bauer EA, McGuire J, Moshell A, editors. Epidermolysis bullosa: clinical, epidemiologic and laboratory advances and the findings of the National Epidermolysis Bullosa Registry. Baltimore: Johns Hopkins University Press. 1999. p. 236-257.
  9. Oral healthcare for patients with epidermolysis bullosa—best clinical practice guidelines. Int J Paediat Dentist 2012;22(Suppl 1):1-35.
  10. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects. Dermatol Online J 2003 Aug;9(3):6.
  11. Epidermolysis bullosa in the eastern province of Saudi Arabia. Int J Dermatol 1993 Aug;32(8):579-581.
  12. Epidermolysis bullosa: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1990 Nov-Dec;31(6):383-387.
  13. Dystrophic epidermolysis bullosa inversa. Dermatologica 1990;181(2):145-148.
  14. Therapeutic efficacy of phenytoin inrecessive dystrophic epidermolysis: a comparison of shortand long-term treatment. Arch Dermatol 1984 Apr;120(4):490-495.
  15. Development defects of enamel in humans with hereditary epidermolysis bullosa. Arch Oral Biol 1993 Nov;38(11):945-955.
  16. Epidermolysis bullosa associated with enamel hypoplasia and taurodontism. J Oral Pathology 1983;12(2):73-83.
  17. Oral manifestations in the epidermolysis bullosa spectrum. Dermatol Clin 2010;28(1):159-164.
  18. Epidermolysis bullosa and dental developmental age. Int J Paediatr Dent 2005 Sep;15(5):335-341.
  19. Dental and anaesthetic management of children with dystrophic epidermolysis bullosa. Int J Paediatr Dent 2009 Mar;19(2):127-134.
  20. Dental caries risk in hereditary epidermolysis bullosa. Pediatr Dent 1994;16(6):427-432.
  21. Ozone therapy in dentistry: a strategic review. J Nat Sc Biol Med 2011;2(2):151-153.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.